Literature DB >> 11157361

Market potential for probiotics.

C Stanton1, G Gardiner, H Meehan, K Collins, G Fitzgerald, P B Lynch, R P Ross.   

Abstract

"Functional foods" as a marketing term was initiated in Japan in the late 1980s and is used to describe foods fortified with ingredients capable of producing health benefits. This concept is becoming increasingly popular with consumers because of a heightened awareness of the link between health, nutrition, and diet. Food manufacturers are enthusiastic about developing such products because the added ingredients give increased value to food. The global market for functional foods in the coming years is predicted to grow rapidly. Although Japan currently accounts for about one-half of this market, the fastest rate of growth is expected to be in the United States. Probiotic products represent a strong growth area within the functional foods group and intense research efforts are under way to develop dairy products into which probiotic organisms such as Lactobacillus and Bifidobacterium species are incorporated. Such probiotic foods may modulate gut microbial composition, thereby leading to improved gut health, for example, through improved tolerance to lactose in lactose-intolerant individuals or improved resistance to pathogenic bacteria. Large numbers of viable microorganisms are likely to be required in the food product, which should be consumed regularly to experience the health effect. The probiotic market, especially dairy products such as yogurts and fermented milks, has experienced rapid growth in Europe. The long-term exploitation of probiotics as health promoters is dependent on several factors, including sound, scientifically proven clinical evidence of health-promoting activity; accurate consumer information; effective marketing strategies; and, above all, a quality product that fulfills consumer expectations.

Entities:  

Mesh:

Year:  2001        PMID: 11157361     DOI: 10.1093/ajcn/73.2.476s

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  43 in total

1.  Genomic diversity and relatedness of bifidobacteria isolated from a porcine cecum.

Authors:  P J Simpson; C Stanton; G F Fitzgerald; R P Ross
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

2.  Culture-independent analysis of probiotic products by denaturing gradient gel electrophoresis.

Authors:  R Temmerman; I Scheirlinck; G Huys; J Swings
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

Review 3.  Probiotics and prebiotics in the elderly.

Authors:  J M T Hamilton-Miller
Journal:  Postgrad Med J       Date:  2004-08       Impact factor: 2.401

Review 4.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

5.  Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 revitalizes its use in combinatorial drug therapy.

Authors:  Sudip Regmi; Yun Hee Choi; Yoon Seok Choi; Mi Ri Kim; Jin Cheol Yoo
Journal:  Folia Microbiol (Praha)       Date:  2016-10-27       Impact factor: 2.099

6.  Identification of two-component regulatory systems in Bifidobacterium infantis by functional complementation and degenerate PCR approaches.

Authors:  Laura E MacConaill; Derek Butler; Mary O'Connell-Motherway; Gerald F Fitzgerald; Douwe van Sinderen
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

7.  Association of beta-glucan endogenous production with increased stress tolerance of intestinal lactobacilli.

Authors:  Helena M Stack; Niamh Kearney; Catherine Stanton; Gerald F Fitzgerald; R Paul Ross
Journal:  Appl Environ Microbiol       Date:  2009-11-20       Impact factor: 4.792

8.  Gastric cancer mortality trends in Spain, 1976-2005, differences by autonomous region and sex.

Authors:  Esther García-Esquinas; Beatriz Pérez-Gómez; Marina Pollán; Elena Boldo; Pablo Fernández-Navarro; Virginia Lope; Enrique Vidal; Gonzalo López-Abente; Nuria Aragonés
Journal:  BMC Cancer       Date:  2009-09-28       Impact factor: 4.430

9.  Genetic and physiological responses of Bifidobacterium animalis subsp. lactis to hydrogen peroxide stress.

Authors:  Taylor S Oberg; Robert E Ward; James L Steele; Jeff R Broadbent
Journal:  J Bacteriol       Date:  2013-06-14       Impact factor: 3.490

10.  Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations.

Authors:  S A Cohen; M C Woodfield; N Boyle; Z Stednick; M Boeckh; S A Pergam
Journal:  Transpl Infect Dis       Date:  2016-09-21       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.